Publication Name	World Journal of Gastroenterology
Manuscript ID	81972
Country	Greece

Received	2022-12-05 21:15
Peer-Review Started	2022-12-05 21:17
To Make the First Decision
Return for Revision	2022-12-19 22:59
Revised	2023-01-04 21:36
Second Decision	2023-03-10 03:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-03-14 19:08
Articles in Press	2023-03-14 19:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-03-20 11:57
Publish the Manuscript Online	2023-03-28 12:59

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Role of autoantibodies in the clinical management of primary biliary cholangitis
Manuscript Source	Invited Manuscript
All Author List	Eirini I Rigopoulou and Dimitrios P Bogdanos
Funding Agency and Grant Number
Corresponding Author	Eirini I Rigopoulou, MD, PhD, Professor, Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Mezourlo, Larissa 41110 , Greece. eirigopoulou@med.uth.gr
Key Words	Primary biliary cholangitis; Anti-mitochondrial antibodies; Primary biliary cholangitis-specific antinuclear antibodies; Anti-sp100; Anti-gp210; Prognosis
Core Tip	The diagnosis of primary biliary cholangitis (PBC) relies on the detection of disease-specific autoantibodies, including anti-mitochondrial antibodies and disease-specific antinuclear antibodies targeting sp100 and gp210. In this review, we summarize existing data on detection of PBC-related autoantibodies and their clinical significance. Moreover, we provide insight on novel autoantibodies and their possible prognostic role in PBC patients.
Publish Date	2023-03-28 12:59
Citation	Rigopoulou EI, Bogdanos DP. Role of autoantibodies in the clinical management of primary biliary cholangitis. World J Gastroenterol 2023; 29(12): 1795-1810
URL	https://www.wjgnet.com/1007-9327/full/v29/i12/1795.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i12.1795

Full Article (PDF)	WJG-29-1795.pdf
Full Article (Word)	WJG-29-1795.docx
Manuscript File	81972_Auto_Edited-LM.docx
Answering Reviewers	81972-Answering reviewers.pdf
Audio Core Tip	81972-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	81972-Conflict-of-interest statement.pdf
Copyright License Agreement	81972-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	81972-Language certificate.pdf
Peer-review Report	81972-Peer-review(s).pdf
Scientific Misconduct Check	81972-Bing-Fan JR-2.png
Scientific Editor Work List	81972-Scientific editor work list.pdf